标题
Covid-19 and immunomodulation in IBD
作者
关键词
-
出版物
GUT
Volume -, Issue -, Pages gutjnl-2020-321269
出版商
BMJ
发表日期
2020-04-18
DOI
10.1136/gutjnl-2020-321269
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China
- (2020) Aiping Wu et al. Cell Host & Microbe
- Predicting, Preventing, and Managing Treatment-related Complications in Patients With Inflammatory Bowel Diseases.
- (2020) Laurent Beaugerie et al. Clinical Gastroenterology and Hepatology
- Evidence for gastrointestinal infection of SARS-CoV-2
- (2020) Fei Xiao et al. GASTROENTEROLOGY
- Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
- (2020) Haibo Zhang et al. INTENSIVE CARE MEDICINE
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Coronavirus infections and immune responses
- (2020) Geng Li et al. JOURNAL OF MEDICAL VIROLOGY
- Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury
- (2020) Clark D Russell et al. LANCET
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
- (2020) Nanshan Chen et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- A new coronavirus associated with human respiratory disease in China
- (2020) Fan Wu et al. NATURE
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia
- (2020) Qun Li et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2
- (2020) Renhong Yan et al. SCIENCE
- Nutritional Aspects in Inflammatory Bowel Diseases
- (2020) Paola Balestrieri et al. Nutrients
- Fecal Serine Protease Profiling in Inflammatory Bowel Diseases
- (2020) Amin Jablaoui et al. Frontiers in Cellular and Infection Microbiology
- The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
- (2020) Nature Microbiology
- Systematic review with meta-analysis: biologics and risk of infection or cancer in elderly patients with inflammatory bowel disease
- (2020) Daniele Piovani et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
- (2020) Chuan Qin et al. CLINICAL INFECTIOUS DISEASES
- Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?
- (2020) Daniel Batlle et al. CLINICAL SCIENCE
- Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms
- (2020) Xi Jin et al. GUT
- Detection of SARS-CoV-2 in Different Types of Clinical Specimens
- (2020) Wenling Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical and immunological features of severe and moderate coronavirus disease 2019
- (2020) Guang Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- SARS-CoV-2: a storm is raging
- (2020) Savannah F. Pedersen et al. JOURNAL OF CLINICAL INVESTIGATION
- Inflammatory Bowel Disease Care in the COVID-19 Pandemic Era: The Humanitas, Milan, Experience
- (2020) Gionata Fiorino et al. Journal of Crohns & Colitis
- Covid‐19 and the digestive system
- (2020) Sunny H Wong et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- COVID-19 spike-host cell receptor GRP78 binding site prediction
- (2020) Ibrahim M. Ibrahim et al. JOURNAL OF INFECTION
- Clinical analysis of pregnant women with 2019 novel coronavirus pneumonia
- (2020) Siyu Chen et al. JOURNAL OF MEDICAL VIROLOGY
- Diagnostic Utility of Clinical Laboratory Data Determinations for Patients with the Severe COVID‐19
- (2020) Yong Gao et al. JOURNAL OF MEDICAL VIROLOGY
- TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib
- (2020) Dandan Wu et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- COVID-19: consider cytokine storm syndromes and immunosuppression
- (2020) Puja Mehta et al. LANCET
- Virological assessment of hospitalized patients with COVID-2019
- (2020) Roman Wölfel et al. NATURE
- Management of IBD during the COVID-19 outbreak: resetting clinical priorities
- (2020) Silvio Danese et al. Nature Reviews Gastroenterology & Hepatology
- Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells
- (2020) Shutoku Matsuyama et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: a single center’s observational study
- (2020) Dan Sun et al. World Journal of Pediatrics
- Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
- (2020) Chaomin Wu et al. JAMA Internal Medicine
- COVID-19 and smoking: A systematic review of the evidence
- (2020) Constantine Vardavas et al. Tobacco Induced Diseases
- Smoking Upregulates Angiotensin-Converting Enzyme-2 Receptor: A Potential Adhesion Site for Novel Coronavirus SARS-CoV-2 (Covid-19)
- (2020) Samuel James Brake et al. Journal of Clinical Medicine
- Implications of COVID-19 for patients with pre-existing digestive diseases
- (2020) Ren Mao et al. Lancet Gastroenterology & Hepatology
- Evolutionary Trajectory for the Emergence of Novel Coronavirus SARS-CoV-2
- (2020) Saif ur Rehman et al. Pathogens
- Real-World Experience with Tofacitinib in IBD at a Tertiary Center
- (2019) Roni Weisshof et al. DIGESTIVE DISEASES AND SCIENCES
- Comparative Risk of Serious Infections With Biologic and/or Immunosuppressive Therapy in Patients with Inflammatory Bowel Diseases: a Systematic Review and Meta-analysis
- (2019) Siddharth Singh et al. Clinical Gastroenterology and Hepatology
- Quantitative Proteomic Analysis Reveals the Deregulation of Nicotinamide Adenine Dinucleotide Metabolism and CD38 in Inflammatory Bowel Disease
- (2019) LongGui Ning et al. Biomed Research International
- Overall and comparative safety of biologic and immunosuppressive therapy in inflammatory bowel diseases
- (2019) Ariela Holmer et al. Expert Review of Clinical Immunology
- Targeting immune cell circuits and trafficking in inflammatory bowel disease
- (2019) Markus F. Neurath NATURE IMMUNOLOGY
- Imbalance of the renin–angiotensin system may contribute to inflammation and fibrosis in IBD: a novel therapeutic target?
- (2019) Mayur Garg et al. GUT
- Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis
- (2019) Bruce E. Sands et al. NEW ENGLAND JOURNAL OF MEDICINE
- An open-label phase 1 clinical trial of the anti-α4β7 monoclonal antibody vedolizumab in HIV-infected individuals
- (2019) Michael C. Sneller et al. Science Translational Medicine
- TNF activity and T cells
- (2018) Amit K. Mehta et al. CYTOKINE
- IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting
- (2018) Alexander R. Moschen et al. Nature Reviews Gastroenterology & Hepatology
- Anti-α4β7 therapy targets lymphoid aggregates in the gastrointestinal tract of HIV-1–infected individuals
- (2018) Mathieu Uzzan et al. Science Translational Medicine
- Randomised trial and open-label extension study of an anti-interleukin-6 antibody in Crohn’s disease (ANDANTE I and II)
- (2017) Silvio Danese et al. GUT
- MAS1 Receptor Trafficking Involves ERK1/2 Activation Through a β-Arrestin2–Dependent PathwayNovelty and Significance
- (2017) Flavia M. Cerniello et al. HYPERTENSION
- The α4β1 Homing Pathway Is Essential for Ileal Homing of Crohnʼs Disease Effector T Cells In Vivo
- (2017) Sebastian Zundler et al. INFLAMMATORY BOWEL DISEASES
- Human T cell immunosenescence and inflammation in aging
- (2017) Arsun Bektas et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome
- (2016) Bita Shakoory et al. CRITICAL CARE MEDICINE
- Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
- (2016) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sustained virologic control in SIV+ macaques after antiretroviral and 4 7 antibody therapy
- (2016) S. N. Byrareddy et al. SCIENCE
- Harnessing the natural inhibitory domain to control TNFα Converting Enzyme (TACE) activity in vivo
- (2016) Eitan Wong et al. Scientific Reports
- Epithelial Cell-Derived a Disintegrin and Metalloproteinase-17 Confers Resistance to Colonic Inflammation Through EGFR Activation
- (2016) Masayuki Shimoda et al. EBioMedicine
- Anti-Inflammatory Action of Angiotensin 1-7 in Experimental Colitis
- (2016) Maitham A. Khajah et al. PLoS One
- Differential effects of α4β7 and GPR15 on homing of effector and regulatory T cells from patients with UC to the inflamed gut in vivo
- (2015) Anika Fischer et al. GUT
- A Phase 2 Study of Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients With Crohn’s Disease
- (2014) William J. Sandborn et al. Clinical Gastroenterology and Hepatology
- Anti-TNF-α therapy for patients with sepsis: a systematic meta-analysis
- (2014) S. Lv et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Upregulation of circulating components of the alternative renin-angiotensin system in inflammatory bowel disease: A pilot study
- (2014) Mayur Garg et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn's disease
- (2014) Raja Atreya et al. NATURE MEDICINE
- Adult haemophagocytic syndrome
- (2013) Manuel Ramos-Casals et al. LANCET
- Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
- (2013) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
- (2013) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- IL-23: One cytokine in control of autoimmunity
- (2012) Andrew L. Croxford et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation
- (2012) Tatsuo Hashimoto et al. NATURE
- Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis
- (2012) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease
- (2012) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting IL-23 and Th17-Cytokines in Inflammatory Bowel Diseases
- (2010) Daniela De Nitto et al. CURRENT PHARMACEUTICAL DESIGN
- Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
- (2010) Jean Frédéric Colombel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting the Degradation of Angiotensin II With Recombinant Angiotensin-Converting Enzyme 2
- (2009) Jan Wysocki et al. HYPERTENSION
- Effects of the ACE2 inhibitor GL1001 on acute dextran sodium sulfate-induced colitis in mice
- (2009) John J. Byrnes et al. INFLAMMATION RESEARCH
- A Randomized Trial of Ustekinumab, a Human Interleukin-12/23 Monoclonal Antibody, in Patients With Moderate-to-Severe Crohn's Disease
- (2008) William J. Sandborn et al. GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started